Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Liabilities and Shareholders Equity (2023 - 2025)

Ardent Health (ARDT) has 3 years of Liabilities and Shareholders Equity data on record, last reported at $5.2 billion in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 7.38% year-over-year to $5.2 billion; the TTM value through Sep 2025 reached $20.0 billion, up 41.79%, while the annual FY2024 figure was $5.0 billion, 4.75% up from the prior year.
  • Liabilities and Shareholders Equity reached $5.2 billion in Q3 2025 per ARDT's latest filing, up from $5.0 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $5.2 billion in Q3 2025 and bottomed at $4.6 billion in Q2 2024.
  • Average Liabilities and Shareholders Equity over 3 years is $4.9 billion, with a median of $4.9 billion recorded in 2025.
  • Peak YoY movement for Liabilities and Shareholders Equity: rose 4.75% in 2024, then rose 9.08% in 2025.
  • A 3-year view of Liabilities and Shareholders Equity shows it stood at $4.7 billion in 2023, then grew by 4.75% to $5.0 billion in 2024, then grew by 4.0% to $5.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $5.2 billion in Q3 2025, $5.0 billion in Q2 2025, and $4.9 billion in Q1 2025.